VYNE Therapeutics (VYNE) Asset Utilization Ratio (2018 - 2026)

VYNE Therapeutics' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.02 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 71.47% year-over-year to 0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02 (up 71.47% YoY) and the FY2025 annual result came in at 0.01, up 93.31% from the prior year.
• Asset Utilization Ratio was 0.02 for Q1 2026 at VYNE Therapeutics, up from 0.01 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.02 in Q1 2026 and bottomed at 0.0 in Q1 2024.
• A 5-year average of 0.01 and a median of 0.01 in 2023 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 91.65% — and 2025, when it surged 137.01%.
• VYNE Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then plunged by 41.53% to 0.01 in 2023, then grew by 5.2% to 0.01 in 2024, then soared by 42.05% to 0.01 in 2025, then surged by 67.97% to 0.02 in 2026.
• Business Quant data shows VYNE's Asset Utilization Ratio at 0.02 in Q1 2026, 0.01 in Q2 2025, and 0.01 in Q1 2025.